MoneyWorks4Me

The Sales for the quarter ended June 2026 of Rs. 5966.00 million declined by -49.98% from Rs. 11927.00 millions.The company reported a drastic decline of -83.93% in the quarter ended June 2026 to Rs. 746.00  millions from Rs. 4641.00 millions  .The Operating Profit of the company witnessed a decrease to 1543.00 millions from 5993.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 5966.00 11927.00 -49.98 5966.00 11927.00 -49.98 35946.00 40945.00 -12.21
Other Income 483.00 596.00 -18.96 483.00 596.00 -18.96 2811.00 3213.00 -12.51
PBIDT 1543.00 5993.00 -74.25 1543.00 5993.00 -74.25 15860.00 24656.00 -35.67
Interest 96.00 26.00 269.23 96.00 26.00 269.23 323.00 196.00 64.80
PBDT 1447.00 5967.00 -75.75 1447.00 5967.00 -75.75 15537.00 24460.00 -36.48
Depreciation 427.00 538.00 -20.63 427.00 538.00 -20.63 1896.00 2200.00 -13.82
PBT 1020.00 5429.00 -81.21 1020.00 5429.00 -81.21 13641.00 22260.00 -38.72
TAX 274.00 788.00 -65.23 274.00 788.00 -65.23 826.00 3756.00 -78.01
Deferred Tax 164.00 -272.00 -160.29 164.00 -272.00 -160.29 -1858.00 -319.00 482.45
PAT 746.00 4641.00 -83.93 746.00 4641.00 -83.93 12815.00 18504.00 -30.74
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 25.86 50.25 -48.53 25.86 50.25 -48.53 44.12 60.22 -26.73

Natco Pharma Share Price

882.50 4.75 (0.54%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: